CASE PRESENTATION OF URINARY TRACT INFECTION BY STENOTROPHOMONAS MALTOPHILIA
- Authors: Seitopoulou C.1, Stamouli M.2, Kalliora G.3, Mourtzikou A.4
-
Affiliations:
- Laboratory of Biopathology, Nikea Prime Care Center, 2nd YPE, Greece
- Laboratory of Biochemistry, Naval and Veterans Hospital of Athens, Greece
- Faculty of Biology, National and Kapodistrian University of Athens, EKPA, Greece
- Department of Microbiology, Laboratory of Molecular Diagnostics, GHNP “Agios Panteleimon”, Greece
- Section: SHORT COMMUNICATIONS
- URL: https://iimmun.ru/iimm/article/view/12109
- DOI: https://doi.org/10.15789/2220-7619-CPO-12109
- ID: 12109
Cite item
Full Text
Abstract
Stenotrophomonas maltophilia is an emerging aerobic, non-fermentative, gram-negative multidrug-resistant global opportunistic bacillus. S. maltophilia causes a wide range of infections including respiratory tract infections, blood stream infections and, less commonly, biliary tract infections, skin and soft tissue infections, as well as bone and joint infections. It is increasingly being reported to cause urinary tract infections (UTIs). As for the case report, a 87-year-old male patient visited the Biopathology Laboratory of Nikea Primary Healthcare Center, Piraeus, Greece, for routine examination, being referred by the family doctor (GP). Patient history revealed diabetes mellitus type 2, arterial hypertension, hypercholesterolemia, hypertriglyceridemia, hyperuricemia, chronic obstructive pulmonary disease, diagnosed before 30 years prostate cancer Gleasongrade 6, operated before 15 years, followed by hormone therapy and radiation therapy. Patient history also revealed urinary tract stones with 3 episodes of obstructive pyelonephritis during the last 5 years, followed by hospital admissions and administration of intravenous antibiotic treatment. During the hospital admissions, he had a permanent bladder catheter and received special antimicrobial treatment, for various microorganisms detected in his urine samples, such as Escherichia coli, Klebsiella pneumoniae, Proteus mirabilisand Enterococcus faecalis. Urinary incontinence has been a symptom for 15 years, after the prostate cancer surgery. Moreover, during the last 5 years, the patient faced many difficulties in his daily life because of the urinary incontinence. The situation was managed by bladder catheterisation, which further worsened his condition with recurrent UTIs and new episodes of pyelonephritis with subsequent hospitalization.Urinalysis showed proteinuria, intense pyuria, abundance of micro-organisms and abundance of red blood cells. The urine culture grew monomicrobial Stenotrophomonas maltophilia >105CFU/ml. The bacterium was identified by the RapIDTM REMEL ONE identification system (Thermo Fisher Scientific). Antimicrobial susceptibility testing revealed susceptibility toTrimethoprime/Sulfamethoxazole, Levofloxacin, Ceftriaxone and moderatesusceptibility to Ciprofloxacin and Norfloxacin .The patient received treatment with Trimethoprime/Sulfamethoxazole.
About the authors
Christina Seitopoulou
Laboratory of Biopathology, Nikea Prime Care Center, 2nd YPE, Greece
Email: xseitopoulou@yahoo.gr
MD, MSc in Occupational and Enviromental Health, PhDc, Biopathologist, Laboratory of Biopathology, Nikea Prime Care Center, 2nd YPE, Greece
Greece, Laboratory of Biopathology, Nikea Prime Care Center, 2nd YPE, GreeceMarilena Stamouli
Laboratory of Biochemistry, Naval and Veterans Hospital of Athens, Greece
Email: marilena_stamouli@yahoo.com
BSc, MSc in Health management, MSc in TQM, EurSpLM, Director of Biochemistry Laboratory, Naval and Veterans Hospital of Athens (“NNA”), Greece
Greece, Laboratory of Biochemistry, Naval and Veterans Hospital of Athens, GreeceGeorgia Kalliora
Faculty of Biology, National and Kapodistrian University of Athens, EKPA, Greece
Email: georginakall3@gmail.com
Student at Faculty of Biology, National and Kapodistrian University of Athens (EKPA), Greece
Greece, Faculty of Biology, National and Kapodistrian University of Athens, EKPA, GreeceAntonia Mourtzikou
Department of Microbiology, Laboratory of Molecular Diagnostics, GHNP “Agios Panteleimon”, Greece
Author for correspondence.
Email: antoniamour@yahoo.com
BSc, MSc in Clinical Chemistry, MPH, MPHM, EurSpLM, PhD, Scientific Senior Supervisor, Laboratory of Molecular Diagnostics, GHNP “Agios Panteleimon”, Greece
Greece, Department of Microbiology, Laboratory of Molecular Diagnostics, GHNP “Agios Panteleimon”, GreeceReferences
- Said M.S., Tirthani E., Lesho E. Stenotrophomonas Maltophilia. In: StatPearls Treasure Island (FL): StatPearls Publishing; 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK572123/
- An S., Berg G. Stenotrophomonas maltophilia. Trends Microbiol., 2018, vol. 26, no 7, pp. 637–638.
- Liu B., Tong S. An investigation of Stenotrophomonas maltophilia-positive culture caused by fiberoptic bronchoscope contamination. BMC Infect Dis., 2019, vol. 19, no 1, pp.1072.
- Gupta P., Kale P., Khillan V. Resurgence of global opportunistic multidrug-resistant Stenotrophomonas maltophilia. Indian J Crit Care Med., 2018, vol. 22, no 7, pp. 503–508.
- Mojica M.F., Humphries R., Lipuma J.J., Mathers A.J., Rao G.G., Shelburne S.A. et al. Clinical challenges treating Stenotrophomonas maltophilia infections: an update, JAC-Antimicrobial Resistance., 2022, vol. 4, no 3, pp. dlac040.
- Umar Z., Ashfaq S., Parikh A., Ilyas U., Foster A., Bhangal R., et al. Stenotrophomonas Maltophilia and Urinary Tract Infections: A Systematic Review. Cureus., 2022, vol. 14, no 6, pp. e26184.
- Petca R.C., Dănău R.A., Popescu R.I., Damian D., Mareș C., Petca A., Jinga V. Xanthogranulomatous pyelonephritis caused by Stenotrophomonas maltophilia-the first case report and brief review. Pathogens., 2022, vol. 11, no 1, pp. 81.
- Agri H., Karthikeyan R., Kiranmayee B., Jayakumar V., Yadav A., Vinodhkumar O.R., et al. Stenotrophomonas maltophilia: An Overlooked Enemy Disguised as a Friend. Acta Scientific Microbiology., 2022, vol. 5, no 11, pp. 68-80.
- Alqahtani J.M. Emergence of Stenotrophomonas maltophilia nosocomial isolates in a Saudi children’s hospital Risk factors and clinical characteristics Saudi Medical Journal., 2017, vol. 38, no 5, pp. 521-527.